Completed PHASE3 INTERVENTIONAL NCT00360295

A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

Sponsor: Pfizer

Conditions Pneumonia, Community-Acquired

Interventions Azithromycin SR

Updated 6 times since 2017 Last updated: May 19, 2008 Started: Sep 30, 2006 Primary completion: May 31, 2007 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Pneumonia, Community-Acquired, this trial is completed. The trial is conducted by Pfizer and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Asahi, Japan , Asahikawa, Japan , Daitō, Japan , Emukae, Kitamatsuura, Japan , Fukuoka, Japan , Higashi, Japan , Hirase-cho, Sasebo,, Japan , Hitachi, Japan , Hitachi-Naka, Japan , Isesaki, Japan and 36 more locations